StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis YoY Growth in the U.S. by Quarter

YoY Growth in the U.S. (% USD / cc) (%)

QuarterlyAnnual

Novartis YoY Growth in the U.S.: 38.0% in Q3 2026, down 53.0 pts from a year earlier.

Latest, Q3 2026
38.0%
Period ended Sep 30, 2026
Change on a year earlier
-53.0 pts
91.0% in Q3 2025
History
28 quarters
Since Q4 2019
Sources
28
Documents cited below

Where the Q3 2026 figure comes from

“|| Kisqali | Oncology | HR+/HER2- metastatic breast cancer and early breast cancer | 1 168 | 38 | 653 | 35 | 35 | 1 821 | 37 | 37”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedYoY Growth in the U.S. (% USD / cc) (%)Year on yearSource
Q3 2026Sep 30, 202638.0%-53.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202639.0%-61.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202658.0%-29.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202545.0%-20.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202591.0%+41.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025100.0%+33.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202587.0%+15.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202465.0%-58.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202450.0%-69.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202467.0%-37.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202472.0%-58.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023123.0%+71.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023119.0%+65.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023104.0%+71.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023130.0%+119.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202252.0%+32.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis YoY Growth in the U.S. (%), quarterly Q4 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-kisqali-us-yoy-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.